Syntermed Receives FDA Clearance for AdreView Tools™

Syntermed's software AdreView Tools, a new application for Emory Cardiac Toolbox, is now FDA cleared and has an expanded indication: first, for the quantitative analysis and display of SPECT AdreViewTM (123I-mIBG) data sets used for evaluation of patients with congestive heart failure, and second, AdreView Tool can be used for the quantitative analysis of SPECT studies.

Full Press Release

Search By Tags
No tags yet.